Evidence map›Paper›PMID 40529717›Full record

ReviewFrontiers in public health2025

The Hajj legacy and Saudi Arabia's exemplary response to COVID-19.

Ghadah Alsaleh, Bander Balkhi, Ahmed Alahmari, Anas Khan

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ghadah AlsalehGlobal Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Bander BalkhiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ahmed AlahmariGlobal Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Anas KhanGlobal Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic required strong public health measures globally. Saudi Arabia's effective pandemic management, leveraging its experience with mass gatherings such as the Hajj pilgrimage, has been lauded globally. This study was developed using a narrative synthesis approach, based on a structured review of peer-reviewed literature (PubMed and Scopus) and official sources (Saudi MoH and the WHO) covering March 2020-December 2024. This study examines Saudi Arabia's response to the COVID-19 pandemic, with particular emphasis on the strategies implemented to safeguard the Hajj pilgrimage. The analysis is framed within the context of the World Health Organization's (WHO) COVID-19 After Action Review pillars, providing a structured evaluation of the Kingdom's efforts to mitigate risks and protect both pilgrims and the broader population. Topics covered include country-level coordination, risk communication, surveillance, border health, national laboratory systems, infection prevention, case management, operational support, and essential health services. Findings show that preexisting infrastructure and mass-gathering expertise enabled rapid activation of multisectoral task forces, adaptive risk-communication campaigns, and scalable testing and isolation protocols. The Hajj legacy strengthened laboratory diagnostics and surge staffing, informed border screening algorithms, and guided large-event risk assessments. Integrating mass-gathering experience with WHO's framework fostered resilience to complex health emergencies. Saudi Arabia's model offers actionable insights for other nations seeking to harness cultural and organizational strengths in pandemic preparedness.

Indexed as

COVID-19IslamMass GatheringsPublic HealthTravelHumansPandemicsSARS-CoV-2Saudi ArabiaCOVID-19mass gatheringpandemicspublic healthSaudi Arabia

Identifiers

PMID40529717
PMCPMC12171182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.